You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 1109 Next »

PHUSE collaborations are organised into a number of specialist Working Groups, each with a broad topic area. The Working Groups have specific projects designed to achieve a set of particular objectives. This page will highlight the latest news and information from our projects. Participation is open to anyone who wants to contribute and if you would like to get involved, please email workinggroups@phuse.global.

Open Source – Open Source in Pharma, Regulatory Acceptance and Validation

Registration for the Open Source Open Forum is open!

The Open Source Technology in Clinical Data Analysis (OSTCDA) project is hosting their fourth Open Forum: Regulatory Acceptance of Open-Source Submissions, they will be addressing the following questions:

  • Will the FDA accept data and analyses generated with solutions developed and available as open source?
  • Will other regulatory agencies accept data and analyses generated with solutions developed and available as open source?

Come and be a part of our next virtual Open Forum on 12 July at 15:00(BST) 10:00(EDT).

REGISTER HERE

Understanding the Complete Journey of RWD, from Data Source to Final Analysis 

Registration for the RWE Community Forum is open!

The Real World Evidence Working Group is hosting their third Community Forum of the year! This forum will looking at 'Understanding the Complete Journey of RWD, from Data Source to Final Analysis'. As an industry, we are continuously accumulating experiences in working with real-world data (RWD) sources that collectively yield benefits – from enhanced generalisability of findings to facilitating faster approval timelines. However, these efforts are not without their challenges.

Come and be a part of our next virtual Community Forum on 11 July at 14:00(BST) 9:00(EDT).

REGISTER HERE

The Quality and Reusability of Real World Data project within Real World Evidence, has published two new Blogs! The 'Understanding the Data Quality Issues in Real-World Data Through Real-World Examples', blog takes a closer look at the experiences shared within the dedicated Working Group in exploring the types of data quality hurdles encountered when using Real-World Data (RWD). The 'Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products' blog explores the use of Real-World Evidence (RWE) as a powerful tool for informing regulatory decisions and advancing medical innovation.

The Best Data Practices for Rare Disease Patient Foundations and Researchers within the Real World Evidence Working Group, has published a new deliverable in the form of a Poster. The Poster provides an overview of Ensuring Registry Data Relevance and Reliability for Regulatory Use

The Educate the General Population on Data Privacy and Data Sharing project, within the Data Transparency Working Group has published video 2 of their series. The 'What Will I Receive and When Will I Receive It?The video covers topics such as the concept of consent to participate in a clinical trial, an overview of trial design and treatment procedures to develop a strong foundational understanding of clinical trials. To view the full series of videos created by this team, visit the PHUSE website

The Enhanced Risk-based Quality Management (RBQM) Approaches for First-in-Human and/or Small Clinical Trials a new project within Risk Based Quality Management Working Group is now calling for volunteers. This project aims to to discuss and focus on a robust strategy/process and best practices for:

  • Identifying critical items
  • Risk Based data review approaches
  • Risk Based Monitoring approach strategy (tSDV/tSDR)
  • Usage of analytical tools and methods for data review & central monitoring, including limitations on (statistical) methodologies
  • Identification of thresholds or equivalent on limited patient data
  • Targeted medical review
  • Strategy to adequately anticipate on highly dynamic dataEstablish links with the other work streams on FIH/small studies focus

If you would like to volunteer or learn more about this project, email workinggroups@phuse.global. Closing date: 5 July

Multiple projects within Working Groups are open to join. PHUSE welcomes new members who can apply their knowledge to bring fresh ideas and contribute to the ongoing work of PHUSE projects. For more information, click here, read the Welcome Pack or email workinggroups@phuse.global

The Safety Analytics Working Group are pleased to welcome two new Leads to the team: Mac Gordon and Ellis F Unger.

Mac Gordon has a master’s in statistics and graduate certificates in public health, pharmacovigilance and pharmacoepidemiology and has been with Johnson & Johnson for 15 years and in industry for 20 years and Ellis is a board-certified cardiologist, who retired from the US Food and Drug Administration following a 24-year career, where he served in senior leadership roles in the Office of New Drugs, Center for Drug Evaluation and Research (CDER).

They will be joining the current Leads Mary Nilsson, Greg Ball and Scott Proestel, you can learn more about the new leads via the Safety Analytics page.

The Optimizing the Use of Data Standards Working Group are pleased to welcome two new Leads to the team: Sandra VanPelt Nguyen and Edwin van Stein.

Sandra has been involved with PHUSE since 2015, leading and supporting PHUSE projects under the Optimizing the Use of Data Standards and the Real World Evidence Working Groups. Edwin is an active PHUSE member, contributing to the PHUSE EU Connect as a presenter, Stream Chair and Connect Chair, and as a PHUSE Wiki Administrator. He is currently a permanent member of the EU and US Connect Planning Committees and a Working Group Lead.

They will be joining the Current Leads Jane Owens and Janet Low, you can learn more about the new leads via the Optimizing the Use of Data Standards page.

Working Groups Report: Includes project updates, recent and upcoming deliverables and future plans for each Working Group.

Monthly Mailings: The monthly newsletter. Here you will find a full update from each month of the year, easily accessible and divided into key areas of PHUSE.

PHUSE Blogs: Fancy a quick read? A blog is a perfect way to catch up on all things Working Groups. Get the lowdown on the latest events from across the globe and stay updated on industry topics brought to you by industry professionals. 

Initiate and lead a new project under the PHUSE Working Groups umbrella. The new project must address problems of significant relevance to computational science related to drug, biological and device development and must meet all of the guidelines for projects within the collaboration, including the following mandatory requirements: 

  • The projects must address significant research issues relevant to Computational Science
  • The project must not attempt to address FDA policy issues
  • There must be at least one Project Lead personally involved in planning and carrying out the project

New projects can be submitted anytime during the year, click here to submit. 

  • No labels